Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Canc
about
Postoperative adjuvant chemotherapy in rectal cancer operated for cureAdjuvant chemotherapy for rectal cancer: Is it needed?Rectal cancer: An evidence-based update for primary care providersPostoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS studyAdjuvant chemotherapyEfficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis.A new volume of Acta Oncologica.Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: do we have indications for individual risk stratification?Patterns of recurrence in patients achieving pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancerRegional hyperthermia added to intensified preoperative chemo-radiation in locally advanced adenocarcinoma of middle and lower rectum.Overview of radiation therapy for treating rectal cancer.Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer.Therapeutic approaches in the management of locally advanced rectal cancer.Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-α.Strategies to improve outcomes in esophageal adenocarcinoma.Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiationWhich is the best postoperative chemotherapy regimen in patients with rectal cancer after neoadjuvant therapy?Impression of prognosis regarding pathologic stage after preoperative chemoradiotherapy in rectal cancer.Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiationManagement of oligometastatic rectal cancer: is liver first?The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer.Critical evaluation of the scientific content in clinical practice guidelines.EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients.Oncologic outcomes of primary and post-irradiated early stage rectal cancer: a retrospective cohort studyRadiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancerLong-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategiesNeoadjuvant treatment in rectal cancer: actual status.Combination of carbon ion beam and gemcitabine causes irreparable DNA damage and death of radioresistant pancreatic cancer stem-like cells in vitro and in vivo.Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future.Neoadjuvant treatment response as an early response indicator for patients with rectal cancerPost-treatment surveillance in colorectal cancerPrognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy.Rectal adenocarcinoma: proposal for a model based on pretreatment prognostic factors.Treatment of locally advanced rectal cancer: controversies and questions.Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.Mortality risk after preoperative versus postoperative chemotherapy and radiotherapy in lymph node-positive rectal cancer.Wait-and-see or radical surgery for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy: a cohort studyYpT1-2N0 rectal cancer after neoadjuvant chemoradiation has lower survival compared with pT1-2N0 rectal cancer.An individualized conditional survival calculator for patients with rectal cancer
P2860
Q24201072-7FAE19BF-D5FE-4708-BB18-B96FE28F7F7CQ26775099-10E88A3D-8737-4530-978B-5E79F8C345A4Q27013068-BE803F43-B866-4629-AADE-C4B29448DE5EQ30744596-C93B0E27-81F3-4919-B62A-89F910B1F1D6Q33394804-F53F980A-D63F-4FD3-A49D-202EF3ED8489Q33698724-EB367AB7-BC77-4E6B-8B29-F4B097791BBAQ33749847-6A8DDC4B-A6AD-4B60-9CE7-0BC19C4111A4Q33776941-463EFD78-8B82-44C7-922C-710A98BCFD47Q33828595-2EBFFCD3-BAF2-407F-B9F9-CF1AE6AC0FC0Q33890616-EF7550FE-0020-494E-AC30-42C39A9528D7Q34098024-BED414B8-C266-489D-A719-EDFBD6410058Q34136267-09F98EDA-D6DF-459E-B5EF-A3346178F0B8Q34169310-7E12295E-427C-4373-91BD-FE03E6DB3A66Q34234928-9C98E098-7215-45DB-84A7-554F4244DDE8Q34255956-CCCCA3BE-12A9-4494-BAD0-B49A10F19B77Q34409666-C132CEE2-BF00-4065-B719-E6D6EEF8C311Q34499179-A1912AE0-F03B-4C7C-B07D-53D7BB033FB5Q34630015-8929E4A9-FB1D-4E67-ACB6-21CB672E5090Q34932625-F8866937-3178-4E45-A186-9E65BB789CB3Q34989484-6E4BE42F-3F34-4EB0-BCE3-1CB8091B82CFQ35029056-40536ED7-B4BA-4B49-A325-8394FC7A5B91Q35058997-0D3CE550-3E27-4DA6-8F90-BDC62FB041CEQ35117790-99D51AC4-C64C-4ACC-9EC9-E2A71C25DF3AQ35146143-A9D82AD5-622E-4F58-B488-84B6DFD170E9Q35171544-293AA031-8E72-4D8A-8996-1ED8C1E4F670Q35528886-FE009676-8DAC-4B11-9FCF-364C518698FFQ35569457-DC6FD6E0-767C-42B4-A789-A8EE379B5FAAQ35687452-96391776-E669-4A48-B915-A25D4336B9A2Q35742348-62B33A9A-F1C7-4CD7-B175-A2A61D973EB8Q35920508-EDA3D1C5-CEC1-4E4A-9E75-CF42B9E24E11Q36058487-23283BCA-594B-4606-8D73-020F0CA53C82Q36177668-D436BC2A-0B40-4C4F-B5C1-EA25F63F6A26Q36307615-E66B9C5C-7C0F-43EB-9338-5029DC6ABE74Q36349876-12E5D951-B1FD-46EA-B6D5-9D99980A1FC7Q36351882-F531BF07-AF43-4578-89DF-5C66F6AB6BDDQ36540452-E065A91A-4C26-4AD5-A516-900F1F9E527EQ36551503-96BD3631-39EE-4CBE-A7E6-D2DCBD751A7DQ36561777-51E84DC5-A2A4-4E8E-B559-5617D407856EQ36562267-DCAA56F8-90B4-428D-B64C-4DB9C2408C4AQ36905075-9BC58FF1-12AF-437B-96F0-DF3F39F96E0D
P2860
Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Canc
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Patients with curative resecti ...... Research and Treatment of Canc
@en
Patients with curative resecti ...... Research and Treatment of Canc
@nl
type
label
Patients with curative resecti ...... Research and Treatment of Canc
@en
Patients with curative resecti ...... Research and Treatment of Canc
@nl
prefLabel
Patients with curative resecti ...... Research and Treatment of Canc
@en
Patients with curative resecti ...... Research and Treatment of Canc
@nl
P2093
P921
P356
P1476
Patients with curative resecti ...... Research and Treatment of Canc
@en
P2093
European Organisation for Research and Treatment of Cancer Radiation Oncology Group
France Nguyen
Gilles Calais
Jean-Francois Bosset
Laurence Collette
Laurent Mineur
Ljiljana Radosevic-Jelic
Marcel den Dulk
Marianne Piérart
Philippe Maingon
P304
P356
10.1200/JCO.2007.11.9685
P407
P577
2007-10-01T00:00:00Z